Related Experiment Video
Updated: Jul 6, 2026

08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Can protons improve SBRT for lung lesions? Dosimetric considerations
Dietmar Georg1, Martin Hillbrand, Markus Stock
1Department of Radiotherapy, Medical University Vienna/AKH Vienna, Vienna, Austria. Dietmar.Georg@akhwien.at
Summary
Proton therapy shows minor dosimetric benefits over photon techniques for hypofractionated stereotactic body radiotherapy (SBRT). While both methods offer lung lesion treatment, further clinical studies are needed to confirm if these small advantages improve outcomes.
Area of Science:
- Radiation Oncology
- Medical Physics
Background:
- Hypofractionated stereotactic body radiotherapy (SBRT) is an advanced cancer treatment.
- Proton therapy offers potential advantages over traditional photon therapy due to its physical properties.
Purpose of the Study:
- To investigate the dosimetric benefits of proton therapy (PT) and intensity modulated proton therapy (IMPT) compared to 3D conformal photon therapy (3D-CRT).
- To evaluate these techniques under different breathing conditions for SBRT of lung lesions.
Main Methods:
- Retrospective analysis of 12 patients undergoing hypofractionated SBRT (3x15Gy).
- Comparison of passively scattered protons (PT), intensity modulated proton therapy (IMPT), and 3D-CRT.
- Evaluation of shallow breathing with abdominal compression (SB+AC) versus deep inspiration breath hold (DIBH) techniques.
- Dosimetric analysis of planning target volume (PTV), lung, heart, and esophagus using dose-volume histograms (DVH).
Main Results:
- Proton techniques (PT and IMPT) demonstrated superior sparing of the heart and contralateral lung compared to 3D-CRT.
- PT and IMPT achieved near-zero maximum doses to the heart and esophagus, significantly lower than 3D-CRT.
- IMPT showed a greater reduction in irradiated lung volume (V2Gy) compared to PT and 3D-CRT.
- Deep inspiration breath hold (DIBH) improved DVHs for the ipsilateral lung across all treatment modalities.
Conclusions:
- Proton therapy offers modest dosimetric advantages for SBRT of lung lesions compared to photon therapy.
- The clinical significance of these dosimetric benefits regarding side effects and local control requires further investigation in clinical trials.

